Sarcoidosis: A comprehensive review and update for the dermatologist: Part I. Cutaneous disease

Journal of the American Academy of Dermatology

Volumn 66, Issue 5, 2012, Pages 699.e1-699.e18

  Haimovic, Adele ^a   Sanchez, Miguel ^a   Judson, Marc A ^b   Prystowsky, Stephen ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIINFLAMMATORY AGENT; CHLOROQUINE; CLOBETASOL; CORTICOSTEROID; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; MINOCYCLINE; TETRACYCLINE; THALIDOMIDE; TRIAMCINOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ULOBETASOL PROPIONATE;

ACNE; AFRICAN AMERICAN; ALLERGIC REACTION; ANAPHYLAXIS; ATROPHY; CUSHING SYNDROME; CUTANEOUS SARCOIDOSIS; DEFORMITY; DEMYELINATING DISEASE; DERMATOLOGIST; DIABETES MELLITUS; DISEASE SEVERITY; DIZZINESS; ENVIRONMENTAL FACTOR; ERYTHEMA NODOSUM; ETHNICITY; EVIDENCE BASED PRACTICE; FOLLICULITIS; GASTROINTESTINAL SYMPTOM; GENETICS; HEADACHE; HUMAN; HYPERSENSITIVITY; HYPERTENSION; HYPOPIGMENTATION; INCREASED APPETITE; INFECTION; INJECTION SITE REACTION; LIVER NECROSIS; LIVER TOXICITY; LYMPHOMA; MONOTHERAPY; MOOD DISORDER; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; OSTEOPOROSIS; PANCYTOPENIA; PATHOGENESIS; PERIPHERAL NEUROPATHY; PHENOTYPE; PHOTOTOXICITY; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; PURPURA; RACE; RETINOPATHY; REVIEW; SARCOIDOSIS; SCALP; SCAR FORMATION; SEDATION; SEX DIFFERENCE; SIDE EFFECT; SKIN DISEASE; SKIN MANIFESTATION; STRIA; TELANGIECTASIA; TERATOGENICITY; TOOTH DISCOLORATION; TUBERCULOSIS; VAGINA CANDIDIASIS; VASCULAR NECROSIS; VEIN THROMBOSIS; WEIGHT GAIN;

EID: 84859845984     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.11.965     Document Type: Review

References (170)

1. Brownell I, Ramirez-Valle F, Sanchez M, Prystowsky S. Evidence for mycobacteria in sarcoidosis. Am J Respir Cell Mol Biol 2011;45:899-905.
2. Gupta D, Agarwal R, Aggarwal AN, Jindal SK. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J 2007;30:508-16. (Pubitemid 351182075)
3. Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004;170:1324-30. (Pubitemid 39657197)
4. Chen ES, Moller DR. Sarcoidosis - scientific progress and clinical challenges. Nat Rev Rheumatol 2011;7:457-67.
5. Mana J, Marcoval J, Graells J, Salazar A, Peyri J, Pujol R. Cutaneous involvement in sarcoidosis. Relationship to systemic disease. Arch Dermatol 1997;133:882-8. (Pubitemid 27337549)
6. English JC 3rd, Patel PJ, Greer KE. Sarcoidosis. J Am Acad Dermatol 2001;44:725-43. (Pubitemid 32391159)
7. Lodha S, Sanchez M, Prystowsky S. Sarcoidosis of the skin: a review for the pulmonologist. Chest 2009;136:583-96.
8. Costabel U, Guzman J, Baughman RP. Systemic evaluation of a potential cutaneous sarcoidosis patient. Clin Dermatol 2007;25:303-11. (Pubitemid 46863480)
9. Baughman RP. Pulmonary sarcoidosis. Clin Chest Med 2004;25:521-30. (Pubitemid 39149799)
10. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164(10 pt 1):1885-9. (Pubitemid 33152325)
11. Hosoda Y, Sasagawa S, Yasuda N. Epidemiology of sarcoidosis: new frontiers to explore. Curr Opin Pulm Med 2002;8:424-8. (Pubitemid 34836947)
12. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145:234-41.
13. Reich JM, Johnson RE. Incidence of clinically identified sarcoidosis in a northwest United States population. Sarcoidosis Vasc Diffuse Lung Dis 1996;13:173-7. (Pubitemid 26332096)
14. Bresnitz EA, Strom BL. Epidemiology of sarcoidosis. Epidemiol Rev 1983;5:124-56. (Pubitemid 14238316)
15. Pietinalho A, Hiraga Y, Hosoda Y, Lofroos AB, Yamaguchi M, Selroos O. The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study. Sarcoidosis 1995;12:61-7.
16. Cozier YC, Berman JS, Palmer JR, Boggs DA, Serlin DM, Rosenberg L. Sarcoidosis in black women in the United States: data from the Black Women's Health Study. Chest 2011;139:144-50.
17. Hillerdal G, Nou E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984;130:29-32. (Pubitemid 14092975)
18. Byg KE, Milman N, Hansen S. Sarcoidosis in Denmark 1980-1994. A registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:46-52. (Pubitemid 36559733)
19. Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J 2008;31:372-9.
20. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153-65.
21. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336:1224-34. (Pubitemid 27183653)
22. Lazarus A. Sarcoidosis: epidemiology, etiology, pathogenesis, and genetics. Dis Mon 2009;55:649-60.
23. Sharma OP. Sarcoidosis around the world. Clin Chest Med 2008;29:357-63. (Pubitemid 351778214)
24. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003;361:1111-8. (Pubitemid 36369566)
25. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:149-73.
26. Chen ES, Moller DR. Etiology of sarcoidosis. Clin Chest Med 2008;29:365-77. (Pubitemid 351778206)
27. Zaba LC, Smith GP, Sanchez M, Prystowsky SD. Dendritic cells in the pathogenesis of sarcoidosis. Am J Respir Cell Mol Biol 2010;42:32-9.
28. Barnard J, Rose C, Newman L, Canner M, Martyny J, McCammon C, et al. Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS). J Occup Environ Med 2005;47:226-34. (Pubitemid 40365760)
29. Kreider ME, Christie JD, Thompson B, Newman L, Rose C, Barnard J, et al. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 2005;128:207-15. (Pubitemid 40994475)
30. Kern DG, Neill MA, Wrenn DS, Varone JC. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis 1993;148(4 pt 1):974-80. (Pubitemid 23301216)
31. Drake WP, Pei Z, Pride DT, Collins RD, Cover TL, Blaser MJ. Molecular analysis of sarcoidosis tissues for mycobacterium species DNA. Emerg Infect Dis 2002;8:1334-41. (Pubitemid 35334710)
32. Gazouli M, Ikonomopoulos J, Trigidou R, Foteinou M, Kittas C, Gorgoulis V. Assessment of mycobacterial, propionibacterial, and human herpesvirus 8 DNA in tissues of greek patients with sarcoidosis. J Clin Microbiol 2002;40:3060-3. (Pubitemid 35284990)
33. Crowley LE, Herbert R, Moline JM, Wallenstein S, Shukla G, Schechter C, et al. "Sarcoid like" granulomatous pulmonary disease in World Trade Center disaster responders. Am J Ind Med 2011;54:175-84.
34. Agostini C, Adami F, Semenzato G. New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol 2000;12:71-6. (Pubitemid 30036691)
35. Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC. The BTNL2 gene and sarcoidosis susceptibility in African Americans and whites. Am J Hum Genet 2005;77:491-9. (Pubitemid 41192655)
36. Smith G, Brownell I, Sanchez M, Prystowsky S. Advances in the genetics of sarcoidosis. Clin Genet 2008;73:401-12. (Pubitemid 351517253)
37. Rybicki BA, Iannuzzi MC, Frederick MM, Thompson BW, Rossman MD, Bresnitz EA, et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001;164:2085-91. (Pubitemid 34020250)
38. Design of a case control etiologic study of sarcoidosis (ACCESS). ACCESS Research Group. J Clin Epidemiol 1999;52:1173-86.
39. Familial associations in sarcoidosis. A report to the Research Committee of the British Thoracic and Tuberculosis Association. Tubercle 1973;54:87-98.
40. Grunewald J, Brynedal B, Darlington P, Nisell M, Cederlund K, Hillert J, et al. Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients. Respir Res 2010;11:25.
41. Grunewald J. Review: role of genetics in susceptibility and outcome of sarcoidosis. Semin Respir Crit Care Med 2010;31:380-9.
42. Judson MA. Sarcoidosis: lost in translation. Respirology 2011;16:384-5.
43. Iannuzzi MC, Rybicki BA. Genetics of sarcoidosis: candidate genes and genome scans. Proc Am Thorac Soc 2007;4:108-16. (Pubitemid 46067569)
44. Schurmann M, Reichel P, Muller-Myhsok B, Schlaak M, Muller-Quernheim J, Schwinger E. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001;164:840-6. (Pubitemid 32881922)
45. Sanchez M, Prystowsky S. Sarcoidosis of the skin. In: Basow D, editor. UpToDate. Waltham (MA): UpToDate; 2010.
46. Elgart ML. Cutaneous sarcoidosis: definitions and types of lesions. Clin Dermatol 1986;4:35-45.
47. Marchell RM, Judson MA. Cutaneous sarcoidosis. Semin Respir Crit Care Med 2010;31:442-51.
48. Scadding JG, Mitchell DN, editors. Sarcoidosis of the skin. London: Chapman & Hall Medical; 1985. pp. 181-206.
49. Hanno R, Needelman A, Eiferman RA, Callen JP. Cutaneous sarcoidal granulomas and the development of systemic sarcoidosis. Arch Dermatol 1981;117:203-7. (Pubitemid 11123002)
50. Samtsov AV. Cutaneous sarcoidosis. Int J Dermatol 1992;31:385-91.
51. Veien NK, Stahl D, Brodthagen H. Cutaneous sarcoidosis in Caucasians. J Am Acad Dermatol 1987;16(3 pt 1):534-40. (Pubitemid 17035372)
52. Yanardaǧ H, Pamuk ON, Karayel T. Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Respir Med 2003;97:978-82. (Pubitemid 36944130)
53. Mahmoodi M, Ahmad A, Bansal C, Cusack CA. Palisaded neutrophilic and granulomatous dermatitis in association with sarcoidosis. J Cutan Pathol 2011;38:365-8.
54. James DG. Lupus pernio. Lupus 1992;1:129-31.
55. Jorizzo JL, Koufman JA, Thompson JN, White WL, Shar GG, Schreiner DJ. Sarcoidosis of the upper respiratory tract in patients with nasal rim lesions: a pilot study. J Am Acad Dermatol 1990;22:439-43. (Pubitemid 20212397)
56. Spiteri MA, Matthey F, Gordon T, Carstairs LS, James DG. Lupus pernio: a clinico-radiological study of thirty-five cases. Br J Dermatol 1985;112:315-22. (Pubitemid 15127311)
57. Paller AS, Surek C, Silva-Walsh I, Krespi Y, Freinkel RK. Cutaneous sarcoidosis associated with sarcoidosis of the upper airway. Arch Dermatol 1983;119:592-6. (Pubitemid 14229719)
58. Neville E, Mills RG, James DG. Sarcoidosis of the upper respiratory tract and its relation to lupus pernio. Ann N Y Acad Sci 1976;278:416-26.
59. Kerdel FA, Moschella SL. Sarcoidosis. An updated review. J Am Acad Dermatol 1984;11:1-19. (Pubitemid 14084721)
60. Young RJ 3rd, Gilson RT, Yanase D, Elston DM. Cutaneous sarcoidosis. Int J Dermatol 2001;40:249-53. (Pubitemid 32640445)
61. Dumitrescu SM, Schwartz RA, Baredes S, Whitworth JA, McDonald R, Zarbin M, et al. Mutilating facial sarcoidosis. Dermatology 1999;199:265-7.
62. Jacyk WK. Cutaneous sarcoidosis in black South Africans. Int J Dermatol 1999;38:841-5.
63. Sakemi H, Oiwa H. Psoriasiform plaques of sarcoidosis. Intern Med 2009;48:391.
64. Koch LH, Mahoney MH, Pariser RJ. Cutaneous sarcoidosis manifesting as extensive verrucous plaques. Int J Dermatol 2010;49:1458-9.
65. Streit M, Bohlen LM, Braathen LR. Ulcerative sarcoidosis successfully treated with apligraf. Dermatology 2001;202:367-70. (Pubitemid 32664545)
66. Yoo SS, Mimouni D, Nikolskaia OV, Kouba DJ, Sauder DN, Nousari CH. Clinicopathologic features of ulcerative-atrophic sarcoidosis. Int J Dermatol 2004;43:108-12. (Pubitemid 38256441)
67. Ichiki Y, Kitajima Y. Ulcerative sarcoidosis: case report and review of the Japanese literature. Acta Derm Venereol 2008;88:526-8.
68. Albertini JG, Tyler W, Miller OF 3rd. Ulcerative sarcoidosis. Case report and review of the literature. Arch Dermatol 1997;133:215-9. (Pubitemid 27075016)
69. Marchell RM, Judson MA. Chronic cutaneous lesions of sarcoidosis. Clin Dermatol 2007;25:295-302. (Pubitemid 46856831)
70. Krasowska D, Schwartz RA, Wojnowska D, Mackiewicz B, Czelej D. Polymorphous cutaneous and chronic multisystem sarcoidosis. Acta Dermatovenerol Alp Panonica Adriat 2008;17:26-30. (Pubitemid 351542819)
71. Gregg PJ, Kantor GR, Telang GH, Lessin SR, Nowell PC, Vonderheid EC. Sarcoidal tissue reaction in Sézary syndrome. J Am Acad Dermatol 2000;43(2 pt 2):372-6. (Pubitemid 30636543)
72. Wong S, Pearce C, Markiewicz D, Sahota A. Seasonal cutaneous sarcoidosis: a photo-induced variant. Photodermatol Photoimmunol Photomed 2011;27:156-8.
73. Ahmed I, Harshad SR. Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease? J Am Acad Dermatol 2006;54:55-60. (Pubitemid 41832457)
74. Vainsencher D, Winkelmann RK. Subcutaneous sarcoidosis. Arch Dermatol 1984;120:1028-31. (Pubitemid 14094222)
75. Koessler A, Grosshans E, Samain F, Runser C, Bernard F, Heid E. Tumoral sarcoidosis [in French]. Ann Dermatol Venereol 1995;122:783-5. (Pubitemid 26072692)
76. Antonovich DD, Callen JP. Development of sarcoidosis in cosmetic tattoos. Arch Dermatol 2005;141:869-72. (Pubitemid 41058069)
77. Chao SC, Yan JJ, Lee JY. Cutaneous sarcoidosis among Taiwanese. J Formos Med Assoc 2000;99:317-23. (Pubitemid 30644476)
78. James DG. Dermatological aspects of sarcoidosis. Q J Med 1959;28:108-24.
79. Chudomirova K, Velichkova L, Anavi B, Arnaudova M. Recurrent sarcoidosis in skin scars accompanying systemic sarcoidosis. J Eur Acad Dermatol Venereol 2003;17:360-1. (Pubitemid 36575673)
80. Sorabjee JS, Garje R. Reactivation of old scars: inevitably sarcoid. Postgrad Med J 2005;81:60-1. (Pubitemid 40187140)
81. Patel KB, Sharma OP. Nails in sarcoidosis: response to treatment. Arch Dermatol 1983;119:277-8. (Pubitemid 13160913)
82. Santoro F, Sloan SB. Nail dystrophy and bony involvement in chronic sarcoidosis. J Am Acad Dermatol 2009;60:1050-2.
83. Wakelin SH, James MP. Sarcoidosis: nail dystrophy without underlying bone changes. Cutis 1995;55:344-6.
84. Leibowitz MR, Essop AR, Schamroth CL, Blumsohn D, Smith EH. Sarcoid dactylitis in black South African patients. Semin Arthritis Rheum 1985;14:232-7. (Pubitemid 15067303)
85. Sam WM, Lynch PJ, editors. Principles and practice of dermatology. 2nd ed. New York: Churchill Livingstone; 1996. pp. 629-39.
86. Okamoto H, Mizuno K, Imamura S, Nagai S, Izumi T. Erythema nodosumelike eruption in sarcoidosis. Clin Exp Dermatol 1994;19:507-10.
87. Teirstein AS, Krumholtz S. Assessment of serum angiotensin - converting enzyme as a marker of activity in sarcoidosis: a study of 31 patients with erythema nodosum. Mt Sinai J Med 1987;54:144-6. (Pubitemid 17058484)
88. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 1983;52:525-33. (Pubitemid 14245588)
89. Grunewald J, Eklund A. Löfgren's syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med 2009;179:307-12.
90. Paramothayan S, Lasserson T. Treatments for pulmonary sarcoidosis. Respir Med 2008;102:1-9. (Pubitemid 350151832)
91. White ES, Lynch JP 3rd. Current and emerging strategies for the management of sarcoidosis. Expert Opin Pharmacother 2007;8:1293-311. (Pubitemid 47034416)
92. Baughman RP, Lower EE, Kaufman AH. Ocular sarcoidosis. Semin Respir Crit Care Med 2010;31:452-62.
93. Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr, Prystowsky EN, et al. Cardiac sarcoidosis. Am Heart J 2009;157:9-21.
94. Terushkin V, Stern BJ, Judson MA, Hagiwara M, Pramanik B, Sanchez M, et al. Neurosarcoidosis: presentations and management. Neurologist 2010;16:2-15.
95. Volden G. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm Venereol 1992;72:69-71.
96. Khatri KA, Chotzen VA, Burrall BA. Lupus pernio: successful treatment with a potent topical corticosteroid. Arch Dermatol 1995;131:617-8.
97. Callen JP. Intralesional corticosteroids. J Am Acad Dermatol 1981;4:149-51. (Pubitemid 11186165)
98. Verbov J. The place of intralesional steroid therapy in dermatology. Br J Dermatol 1976;94(suppl 12):51-8.
99. Badgwell C, Rosen T. Cutaneous sarcoidosis therapy updated. J Am Acad Dermatol 2007;56:69-83. (Pubitemid 46001778)
100. Veien NK. Cutaneous sarcoidosis: prognosis and treatment. Clin Dermatol 1986;4:75-87.
101. Russo G, Millikan LE. Cutaneous sarcoidosis: diagnosis and treatment. Compr Ther 1994;20:418-21.
102. Doherty CB, Rosen T. Evidence-based therapy for cutaneous sarcoidosis. Drugs 2008;68:1361-83. (Pubitemid 351913434)
103. Schutt AC, Bullington WM, Judson MA. Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study. Respir Med 2010;104:717-23.
104. Hawk A, English J. Cutaneous manifestations of sarcoidosis. In: Williams H, English3rd J, Willions H, Bigby M, Diepgen T, Herxheiner A, et al, editors. Evidence-based dermatology. London: BMJ Books; 2003. pp. 659-72.
105. Siltzbach LE, Teirstein AS. Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis. Acta Med Scand Suppl 1964;425:302-8.
106. Zic JA, Horowitz DH, Arzubiaga C, King LE Jr. Treatment of cutaneous sarcoidosis with chloroquine. Review of the literature. Arch Dermatol 1991;127:1034-40.
107. Mosam A, Morar N. Recalcitrant cutaneous sarcoidosis: an evidence-based sequential approach. J Dermatolog Treat 2004;15:353-9. (Pubitemid 39657845)
108. Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax 1999;54:742-6. (Pubitemid 29341413)
109. Baughman RP, Lower EE. Evidence-based therapy for cutaneous sarcoidosis. Clin Dermatol 2007;25:334-40. (Pubitemid 46856833)
110. Veien NK, Brodthagen H. Cutaneous sarcoidosis treated with methotrexate. Br J Dermatol 1977;97:213-6. (Pubitemid 8175916)
111. Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995;155:846-51.
112. Marshall TG, Marshall FE. Sarcoidosis succumbs to antibiotics- implications for autoimmune disease. Autoimmun Rev 2004;3:295-300. (Pubitemid 38887625)
113. Bachelez H, Senet P, Cadranel J, Kaoukhov A, Dubertret L. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 2001;137:69-73. (Pubitemid 32096360)
114. Stagaki E, Mountford WK, Lackland DT, Judson MA. The treatment of lupus pernio: results of 116 treatment courses in 54 patients. Chest 2009;135:468-76.
115. Veien NK, Stahl D, Brodthagen H. Granulomatous rosacea treated with tetracycline. Dermatologica 1981;163:267-9. (Pubitemid 12246046)
116. Scallon B, Cai A, Solowski N, Rosenberg A, Song XY, Shealy D, et al. Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther 2002;301:418-26. (Pubitemid 34429950)
117. Baughman RP, Judson MA, Teirstein AS, Moller DR, Lower EE. Thalidomide for chronic sarcoidosis. Chest 2002;122:227-32. (Pubitemid 34754167)
118. Oliver SJ, Kikuchi T, Krueger JG, Kaplan G. Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement. Clin Immunol 2002;102:225-36. (Pubitemid 34259256)
119. Nguyen YT, Dupuy A, Cordoliani F, Vignon-Pennamen MD, Lebbe C, Morel P, et al. Treatment of cutaneous sarcoidosis with thalidomide. J Am Acad Dermatol 2004;50:235-41. (Pubitemid 38174281)
120. Heffernan MP, Smith DI. Adalimumab for treatment of cutaneous sarcoidosis. Arch Dermatol 2006;142:17-9. (Pubitemid 43107354)
121. Philips MA, Lynch J, Azmi FH. Ulcerative cutaneous sarcoidosis responding to adalimumab. J Am Acad Dermatol 2005;53:917. (Pubitemid 41501405)
122. Tuchinda C, Wong HK. Etanercept for chronic progressive cutaneous sarcoidosis. J Drugs Dermatol 2006;5:538-40.
123. Khanna D, Liebling MR, Louie JS. Etanercept ameliorates sarcoidosis arthritis and skin disease. J Rheumatol 2003;30:1864-7. (Pubitemid 36962468)
124. Field S, Regan AO, Sheahan K, Collins P. Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanercept. Clin Exp Dermatol 2010;35:795-6.
125. Thielen AM, Barde C, Saurat JH, Laffitte E. Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists. Dermatology 2009;219:59-62.
126. Baughman RP, Lower EE. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:70-4. (Pubitemid 32280539)
127. Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest 2005;127:1064-71. (Pubitemid 40775543)
128. Saleh S, Ghodsian S, Yakimova V, Henderson J, Sharma OP. Effectiveness of infliximab in treating selected patients with sarcoidosis. Respir Med 2006;100:2053-9. (Pubitemid 44514944)
129. Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006;174:795-802. (Pubitemid 44511661)
130. Aguiar M, Marcal N, Mendes AC, Bugalho de Almeida A. Infliximab for treating sarcoidosis patients, Portuguese experience. Rev Port Pneumol 2011;17:85-93.
131. Clementine RR, Lyman J, Zakem J, Mallepalli J, Lindsey S, Quinet R. Tumor necrosis factor-alpha antagonist-induced sarcoidosis. J Clin Rheumatol 2010;16:274-9.
132. Dhaille F, Viseux V, Caudron A, Dadban A, Tribout C, Boumier P, et al. Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases. Dermatology 2010;220:234-7.
133. Toussirot E, Pertuiset E, Kantelip B, Wendling D. Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases. Clin Exp Rheumatol 2008;26:471-5. (Pubitemid 352003220)
134. Josse S, Klemmer N, Moreno-Swirc S, Goeb V, Lequerre T, Vittecoq O. Infliximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient. Joint Bone Spine 2009;76:718-9.
135. Verschueren K, Van Essche E, Verschueren P, Taelman V, Westhovens R. Development of sarcoidosis in etanercepttreated rheumatoid arthritis patients. Clin Rheumatol 2007;26:1969-71. (Pubitemid 47516989)
136. O'Shea FD, Marras TK, Inman RD. Pulmonary sarcoidosis developing during infliximab therapy. Arthritis Rheum 2006;55:978-81. (Pubitemid 44917474)
137. Kerjouan M, Jouneau S, Lena H, Luraine R, Desrues B, Delaval P. Pulmonary sarcoidosis developing during treatment with etanercept [in French]. Rev Mal Respir 2011;28:360-4.
138. Kouba DJ, Mimouni D, Rencic A, Nousari HC. Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis. Br J Dermatol 2003;148:147-8.
139. Bhat P, Cervantes-Castaneda RA, Doctor PP, Anzaar F, Foster CS. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. Ocul Immunol Inflamm 2009;17:185-90.
140. Chaussenot A, Bourg V, Chanalet S, Fornari JM, Lebrun C. Neurosarcoidosis treated with mycophenolate mofetil: two cases [in French]. Rev Neurol (Paris) 2007;163:471-5. (Pubitemid 46931925)
141. Moudgil A, Przygodzki RM, Kher KK. Successful steroidsparing treatment of renal limited sarcoidosis with mycophenolate mofetil. Pediatr Nephrol 2006;21:281-5. (Pubitemid 43115886)
142. Voelter-Mahlknecht S, Benez A, Metzger S, Fierlbeck G. Treatment of subcutaneous sarcoidosis with allopurinol. Arch Dermatol 1999;135:1560-1.
143. Georgiou S, Monastirli A, Pasmatzi E, Tsambaos D. Cutaneous sarcoidosis: complete remission after oral isotretinoin therapy. Acta Derm Venereol 1998;78:457-9. (Pubitemid 28505963)
144. Chong WS, Tan HH, Tan SH. Cutaneous sarcoidosis in Asians: a report of 25 patients from Singapore. Clin Exp Dermatol 2005;30:120-4.
145. Zabel P, Entzian P, Dalhoff K, Schlaak M. Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med 1997;155:1665-9. (Pubitemid 27216674)
146. Pignone AM, Rosso AD, Fiori G, Matucci-Cerinic M, Becucci A, Tempestini A, et al. Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosis. J Pineal Res 2006;41:95-100. (Pubitemid 44141742)
147. Patterson JW, Fitzwater JE. Treatment of hypopigmented sarcoidosis with 8-methoxypsoralen and long wave ultraviolet light. Int J Dermatol 1982;21:476-80. (Pubitemid 12006923)
148. Graefe T, Konrad H, Barta U, Wollina U, Elsner P. Successful ultraviolet A1 treatment of cutaneous sarcoidosis. Br J Dermatol 2001;145:354-5. (Pubitemid 32955374)
149. Karrer S, Abels C, Wimmershoff MB, Landthaler M, Szeimies RM. Successful treatment of cutaneous sarcoidosis using topical photodynamic therapy. Arch Dermatol 2002;138:581-4.
150. Penrose C, Mercer SE, Shim-Chang H. Photodynamic therapy for the treatment of cutaneous sarcoidosis. J Am Acad Dermatol 2011;65:e12-4.
151. Patterson C. Successful treatment of cutaneous sarcoid by photodynamic therapy with minimal discomfort using a fractionated dosing regime. Photodermatol Photoimmunol Photomed 2009;25:276-7.
152. Goodman MM, Alpern K. Treatment of lupus pernio with the flashlamp pulsed dye laser. Lasers Surg Med 1992;12:549-51.
153. 2 laser vaporization for disfiguring lupus pernio. J Cosmet Laser Ther 2002;4:87-90.
154. Gurkov R, Berghaus A. Nasal reconstruction in advanced sinunasal sarcoidosis. Rhinology 2009;47:327-9.
155. Smith R, Haeney J, Gulraiz Rauf K. Improving cosmesis of lupus pernio by excision and forehead flap reconstruction. Clin Exp Dermatol 2009;34:e25-7.
156. Spiteri MA, Taylor SJ. Retinoids in the treatment of cutaneous sarcoidosis. Arch Dermatol 1985;121:1486. (Pubitemid 16202159)
157. Tsuboi H, Yonemoto K, Katsuoka K. A 14-year-old girl with lichenoid sarcoidosis successfully treated with tacrolimus. J Dermatol 2006;33:344-8. (Pubitemid 43943368)
158. Seo SK, Yeum JS, Suh JC, Na GY. Lichenoid sarcoidosis in a 3-year-old girl. Pediatr Dermatol 2001;18:384-7. (Pubitemid 33070702)
159. Smith HR, Black MM. Verrucous cutaneous sarcoidosis. Clin Exp Dermatol 2000;25:98-9.
160. Cather JC, Cohen PR. Ichthyosiform sarcoidosis. J Am Acad Dermatol 1999;40(5 pt 2):862-5. (Pubitemid 29230345)
161. Mayock RL, Bertrand P, Morrison CE, Scott JH. Manifestations of sarcoidosis. Analysis of 145 patients, with a review of nine series selected from the literature. Am J Med 1963;35:67-89.
162. Wirth FA, Gould WM, Kauffman CL. Erythroderma in a patient with arthralgias, uveitis, and dyspnea. Arch Dermatol 1999;135:1411, 1414.
163. Katta R, Nelson B, Chen D, Roenigk H. Sarcoidosis of the scalp: a case series and review of the literature. J Am Acad Dermatol 2000;42:690-2. (Pubitemid 30479900)
164. Mann RJ, Allen BR. Nail dystrophy due to sarcoidosis. Br J Dermatol 1981;105:599-601. (Pubitemid 12231506)
165. Jones E, Callen JP. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. J Am Acad Dermatol 1990;23(3 pt 1):487-9. (Pubitemid 20281685)
166. Moss J, Zic J, Drake W. Mycobacterial infection masquerading as cutaneous sarcoidosis. Clin Exp Dermatol 2009;34:e199-201.
167. Lower EE, Baughman RP. The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci 1990;299:153-7. (Pubitemid 20085232)
168. Webster GF, Razsi LK, Sanchez M, Shupack JL. Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol 1991;24:451-4.
169. Meyerle JH, Shorr A. The use of infliximab in cutaneous sarcoidosis. J Drugs Dermatol 2003;2:413-4.
170. Callejas-Rubio JL, Ortego-Centeno N, Lopez-Perez L, Benticuaga MN. Treatment of therapy-resistant sarcoidosis with adalimumab. Clin Rheumatol 2006;25:596-7. (Pubitemid 44137652)